Eli Lily and Company v The Government of Canada and the Perils of Investor-State Arbitration
Year: 2015
Type: article
Abstract: We live in a world today where it is routine for foreign private companies to sue sovereign countries, claiming that domestic laws interfere with foreign investment activities. Take the case of Eli Lilly v the Government of Canada. Eli Lilly and Company (“Eli Lilly”), a multinational pharmaceutical corporation, is presently suing the Government of Canada (“Canada”), alleging that the invalidation of two patents amounts to an unlawful expropriation of Eli Lilly’s intellectual property. The company claims Canada’s patent laws are arbitrary, discriminatory, and in breach of the minimum standard of treatment owed to foreign investors under the North American Free Trade Agreement (“NAFTA”). The company is seeking damages in excess of half a billion dollars.1
Author: James Billingsley
Language: English
Subfield: Law
Field: Social Sciences
Domain: Social Sciences
Open Access status: bronze
Funder: Government of Canada
OpenAlex ID: W1823910484
